XORTX Therapeutics Inc (TSE:XRTX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
XORTX Therapeutics Inc. has appointed Dr. Michael Bumby as the new Chief Financial Officer, bringing his extensive experience in finance and leadership within the biotech and pharma industries. The appointment is expected to provide strategic financial guidance to the company as it advances its clinical development programs.
For further insights into TSE:XRTX stock, check out TipRanks’ Stock Analysis page.
